TAC (TERT Activator-1)

TAC (TERT Activator-1) is an activator of ERK and MEK used in studies of MAPK / ERK Signaling and DNA Damage Response. It is especially relevant in aging, cancer, and cell signaling models, where defined compound exposure can be linked to mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint activation, DNA repair, and genome-stability control.

By activating ERK and MEK, TAC (TERT Activator-1) can be used to examine mitogenic kinase cascades, proliferation control, and differentiation-linked signaling and checkpoint activation, DNA repair, and genome-stability control. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In aging, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving ERK and MEK
• Pathway perturbation studies connected to MAPK / ERK Signaling and DNA Damage Response
• Gain-of-function pathway-activation studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, TAC (TERT Activator-1) is appropriate when a defined chemical perturbant is needed to connect ERK and MEK with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in aging, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.